Skip to main content
Erschienen in: Breast Cancer 6/2019

07.06.2019 | Original Article

Simultaneous comparison between strain and shear wave elastography of breast masses for the differentiation of benign and malignant lesions by qualitative and quantitative assessments

verfasst von: Tomoyuki Fujioka, Mio Mori, Kazunori Kubota, Yuka Kikuchi, Leona Katsuta, Mai Kasahara, Goshi Oda, Toshiyuki Ishiba, Tsuyoshi Nakagawa, Ukihide Tateishi

Erschienen in: Breast Cancer | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To compare the addition of diagnostic strain elastography (SE) and shear wave elastography (SWE) values to the conventional B-mode ultrasonography in differentiating between benign and malignant breast masses by qualitative and quantitative assessments.

Materials and methods

B-mode ultrasound, SE, and SWE were simultaneously performed using one ultrasound system in 148 breast masses; 88 of them were malignant. The breast imaging reporting and data system category in the B-mode, Tsukuba score (SETsu), Fat-Lesion-Ratio (SEFLR) in SE, and five-point color assessment (SWEcol) and elasticity values (SWEela) in SWE were assessed. The results were compared using the area under the receiver-operating characteristic curve (AUC).

Result

The AUC for B-mode and each elastography were similar (B-mode, 0.889; SETsu, 0.885; SEFLR, 0.875; SWEcol, 0.881; SWEela, 0.885; P > 0.05). The combined sets between B-mode and either of the elastography technique showed good diagnostic performance (B-mode + SETsu, 0.903; B-mode + SEFLR, 0.909; B-mode + SWEcol, 0.919; B-mode + SWEela, 0.914). B-mode + SWEcol and B-mode + SWEela showed a higher AUC than B-mode alone (P = 0.026 and 0.029), and B-mode + SETsu and B-mode + SEFLR showed comparable AUC to B-mode alone (P = 0.196 and 0.085). There was no significant difference between qualitative and quantitative assessments for the combined sets of B-mode and elastography (P > 0.05).

Conclusion

The addition of both SE and SWE to B-mode ultrasound improved the diagnostic performance with increased AUC, and especially SWE was more useful than SE, and no significant difference was found between qualitative and quantitative assessments.
Literatur
1.
Zurück zum Zitat Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68:7–30.CrossRef Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68:7–30.CrossRef
2.
Zurück zum Zitat Kornecki A. Current status of breast ultrasound. Can Assoc Radiol J. 2011;62:31–40.CrossRef Kornecki A. Current status of breast ultrasound. Can Assoc Radiol J. 2011;62:31–40.CrossRef
3.
Zurück zum Zitat Hooley RJ, Scoutt LM, Philpotts LE. Breast ultrasonography: state of the art. Radiology. 2013;268:642–59.CrossRef Hooley RJ, Scoutt LM, Philpotts LE. Breast ultrasonography: state of the art. Radiology. 2013;268:642–59.CrossRef
4.
Zurück zum Zitat D’Orsi CJ, Sickles EA, Mendelson EB, Morris EA. ACR BI-RADS atlas, breast imaging reporting and data system. Reston, VA: American College of Radiology; 2013. D’Orsi CJ, Sickles EA, Mendelson EB, Morris EA. ACR BI-RADS atlas, breast imaging reporting and data system. Reston, VA: American College of Radiology; 2013.
5.
Zurück zum Zitat Rao AA, Feneis J, Lalonde C, Ojeda-Fournier H. A pictorial review of changes in the BI-RADS fifth edition. Radiographics. 2016;36:623–39.CrossRef Rao AA, Feneis J, Lalonde C, Ojeda-Fournier H. A pictorial review of changes in the BI-RADS fifth edition. Radiographics. 2016;36:623–39.CrossRef
6.
Zurück zum Zitat Choi EJ, Lee EH, Kim YM, Chang YW, Lee JH, Park YM, et al. Interobserver agreement in breast ultrasound categorization in the mammography and ultrasonography study for breast cancer screening effectiveness (MUST-BE) trial: results of a preliminary study. Ultrasonography. 2018;38:172–80.CrossRef Choi EJ, Lee EH, Kim YM, Chang YW, Lee JH, Park YM, et al. Interobserver agreement in breast ultrasound categorization in the mammography and ultrasonography study for breast cancer screening effectiveness (MUST-BE) trial: results of a preliminary study. Ultrasonography. 2018;38:172–80.CrossRef
7.
Zurück zum Zitat Shiina T, Nightingale KR, Palmeri ML, Hall TJ, Bamber JC, Barr RG, et al. WFUMB guidelines and recommendations for clinical use of ultrasound elastography, part 1: basic principles and terminology. Ultrasound Med Biol. 2015;41:1126–47.CrossRef Shiina T, Nightingale KR, Palmeri ML, Hall TJ, Bamber JC, Barr RG, et al. WFUMB guidelines and recommendations for clinical use of ultrasound elastography, part 1: basic principles and terminology. Ultrasound Med Biol. 2015;41:1126–47.CrossRef
8.
Zurück zum Zitat Garra BS, Cespedes EI, Ophir J, Spratt SR, Zuurbier RA, Magnant CM, et al. Elastography of breast lesions: initial clinical results. Radiology. 1997;202:79–86.CrossRef Garra BS, Cespedes EI, Ophir J, Spratt SR, Zuurbier RA, Magnant CM, et al. Elastography of breast lesions: initial clinical results. Radiology. 1997;202:79–86.CrossRef
9.
Zurück zum Zitat Itoh A, Ueno E, Tohno E, Kamma H, Takahashi H, Shiina T, et al. Breast disease: clinical application of US elastography for diagnosis. Radiology. 2006;239:341–50.CrossRef Itoh A, Ueno E, Tohno E, Kamma H, Takahashi H, Shiina T, et al. Breast disease: clinical application of US elastography for diagnosis. Radiology. 2006;239:341–50.CrossRef
10.
Zurück zum Zitat Sadigh G, Carlos RC, Neal CH. Dwamena BA. Ultrasonographic differentiation of malignant from benign breast lesions: a meta-analytic comparison of elasticity and BIRADS scoring. Breast Cancer Res Treat. 2012;133:23–35.CrossRef Sadigh G, Carlos RC, Neal CH. Dwamena BA. Ultrasonographic differentiation of malignant from benign breast lesions: a meta-analytic comparison of elasticity and BIRADS scoring. Breast Cancer Res Treat. 2012;133:23–35.CrossRef
11.
Zurück zum Zitat Athanasiou A, Tardivon A, Tanter M, Sigal-Zafrani B, Bercoff J, Deffieux T, et al. Breast lesions: quantitative elastography with supersonic shear imaging–preliminary results. Radiology. 2010;256:297–303.CrossRef Athanasiou A, Tardivon A, Tanter M, Sigal-Zafrani B, Bercoff J, Deffieux T, et al. Breast lesions: quantitative elastography with supersonic shear imaging–preliminary results. Radiology. 2010;256:297–303.CrossRef
12.
Zurück zum Zitat Xu H, Rao M, Varghese T, Sommer A, Baker S, Hall TJ, et al. Axial-shear strain imaging for differentiating benign and malignant breast masses. Ultrasound Med Biol. 2010;36:1813–24.CrossRef Xu H, Rao M, Varghese T, Sommer A, Baker S, Hall TJ, et al. Axial-shear strain imaging for differentiating benign and malignant breast masses. Ultrasound Med Biol. 2010;36:1813–24.CrossRef
13.
Zurück zum Zitat Berg WA, Cosgrove DO, Doré CJ, Schäfer FK, Svensson WE, Hooley RJ, et al. Shear-wave elastography improves the specificity of breast US: the BE1 multinational study of 939 masses. Radiology. 2012;262:435–49.CrossRef Berg WA, Cosgrove DO, Doré CJ, Schäfer FK, Svensson WE, Hooley RJ, et al. Shear-wave elastography improves the specificity of breast US: the BE1 multinational study of 939 masses. Radiology. 2012;262:435–49.CrossRef
14.
Zurück zum Zitat Evans A, Whelehan P, Thomson K, Brauer K, Jordan L, Purdie C, et al. Differentiating benign from malignant solid breast masses: value of shear wave elastography according to lesion stiffness combined with greyscale ultrasound according to BI-RADS classification. Br J Cancer. 2012;107:224–9.CrossRef Evans A, Whelehan P, Thomson K, Brauer K, Jordan L, Purdie C, et al. Differentiating benign from malignant solid breast masses: value of shear wave elastography according to lesion stiffness combined with greyscale ultrasound according to BI-RADS classification. Br J Cancer. 2012;107:224–9.CrossRef
15.
Zurück zum Zitat Song EJ, Sohn YM, Seo M. Diagnostic performances of shear-wave elastography and B-mode ultrasound to differentiate benign and malignant breast lesions: the emphasis on the cutoff value of qualitative and quantitative parameters. Clin Imaging. 2018;50:302–7.CrossRef Song EJ, Sohn YM, Seo M. Diagnostic performances of shear-wave elastography and B-mode ultrasound to differentiate benign and malignant breast lesions: the emphasis on the cutoff value of qualitative and quantitative parameters. Clin Imaging. 2018;50:302–7.CrossRef
16.
Zurück zum Zitat Chang JM, Won JK, Lee KB, Park IA, Yi A, Moon WK. Comparison of shear-wave and strain ultrasound elastography in the differentiation of benign and malignant breast lesions. AJR Am J Roentgenol. 2013;201:347–56.CrossRef Chang JM, Won JK, Lee KB, Park IA, Yi A, Moon WK. Comparison of shear-wave and strain ultrasound elastography in the differentiation of benign and malignant breast lesions. AJR Am J Roentgenol. 2013;201:347–56.CrossRef
17.
Zurück zum Zitat Youk JH, Son EJ, Gweon HM, Kim H, Park YJ, Kim JA. Comparison of strain and shear wave elastography for the differentiation of benign from malignant breast lesions, combined with B-mode ultrasonography: qualitative and quantitative assessments. Ultrasound Med Biol. 2014;40:2336–44.CrossRef Youk JH, Son EJ, Gweon HM, Kim H, Park YJ, Kim JA. Comparison of strain and shear wave elastography for the differentiation of benign from malignant breast lesions, combined with B-mode ultrasonography: qualitative and quantitative assessments. Ultrasound Med Biol. 2014;40:2336–44.CrossRef
18.
Zurück zum Zitat Seo M, Ahn HS, Park SH, Lee JB, Choi BI, Sohn YM, et al. Comparison and combination of strain and shear wave elastography of breast masses for differentiation of benign and malignant lesions by quantitative assessment: preliminary study. J Ultrasound Med. 2018;37:99–109.CrossRef Seo M, Ahn HS, Park SH, Lee JB, Choi BI, Sohn YM, et al. Comparison and combination of strain and shear wave elastography of breast masses for differentiation of benign and malignant lesions by quantitative assessment: preliminary study. J Ultrasound Med. 2018;37:99–109.CrossRef
19.
Zurück zum Zitat Kim HJ, Kim SM, Kim B, La Yun B, Jang M, Ko Y, et al. Comparison of strain and shear wave elastography for qualitative and quantitative assessment of breast masses in the same population. Sci Rep. 2018;8:6197.CrossRef Kim HJ, Kim SM, Kim B, La Yun B, Jang M, Ko Y, et al. Comparison of strain and shear wave elastography for qualitative and quantitative assessment of breast masses in the same population. Sci Rep. 2018;8:6197.CrossRef
20.
Zurück zum Zitat Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48:452–8.CrossRef Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48:452–8.CrossRef
21.
Zurück zum Zitat Levental KR, Yu H, Kass L, Lakins JN, Egeblad M, Erler JT, et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell. 2009;25(139):891–906.CrossRef Levental KR, Yu H, Kass L, Lakins JN, Egeblad M, Erler JT, et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell. 2009;25(139):891–906.CrossRef
22.
Zurück zum Zitat Desmedt C, Haibe-Kains B, Wirapati P, Buyse M, Larsimont D, Bontempi G, et al. Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes. Clin Cancer Res. 2008;14:5158–65.CrossRef Desmedt C, Haibe-Kains B, Wirapati P, Buyse M, Larsimont D, Bontempi G, et al. Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes. Clin Cancer Res. 2008;14:5158–65.CrossRef
23.
Zurück zum Zitat Fujioka T, Kubota K, Kikuchi Y, Tsuchiya J, Tateishi U, Kasaharak M, et al. The feasibility of using 18F-FDG-PET/CT in patients with mucinous breast carcinoma. Nucl Med Commun. 2018;39:1033–8.CrossRef Fujioka T, Kubota K, Kikuchi Y, Tsuchiya J, Tateishi U, Kasaharak M, et al. The feasibility of using 18F-FDG-PET/CT in patients with mucinous breast carcinoma. Nucl Med Commun. 2018;39:1033–8.CrossRef
24.
Zurück zum Zitat Fujioka T, Kubota K, Toriihara A, Machida Y, Okazawa K, Nakagawa T, et al. Tumor characteristics of ductal carcinoma in situ of breast visualized on [F-18] fluorodeoxyglucose-positron emission tomography/computed tomography: results from a retrospective study. World J Radiol. 2016;28(8):743–9.CrossRef Fujioka T, Kubota K, Toriihara A, Machida Y, Okazawa K, Nakagawa T, et al. Tumor characteristics of ductal carcinoma in situ of breast visualized on [F-18] fluorodeoxyglucose-positron emission tomography/computed tomography: results from a retrospective study. World J Radiol. 2016;28(8):743–9.CrossRef
25.
Zurück zum Zitat Chang JM, Park IA, Lee SH, Kim WH, Bae MS, Koo HR, et al. Stiffness of tumours measured by shear-wave elastography correlated with subtypes of breast cancer. Eur Radiol. 2013;23:2450–8.CrossRef Chang JM, Park IA, Lee SH, Kim WH, Bae MS, Koo HR, et al. Stiffness of tumours measured by shear-wave elastography correlated with subtypes of breast cancer. Eur Radiol. 2013;23:2450–8.CrossRef
26.
Zurück zum Zitat Youk JH, Gweon HM, Son EJ, Kim JA, Jeong J. Shear-wave elastography of invasive breast cancer: correlation between quantitative mean elasticity value and immunohistochemical profile. Breast Cancer Res Treat. 2013;138:119–26.CrossRef Youk JH, Gweon HM, Son EJ, Kim JA, Jeong J. Shear-wave elastography of invasive breast cancer: correlation between quantitative mean elasticity value and immunohistochemical profile. Breast Cancer Res Treat. 2013;138:119–26.CrossRef
27.
Zurück zum Zitat Evans A, Whelehan P, Thomson K, McLean D, Brauer K, Purdie C, et al. Invasive breast cancer: relationship between shear-wave elastographic findings and histologic prognostic factors. Radiology. 2012;263:673–7.CrossRef Evans A, Whelehan P, Thomson K, McLean D, Brauer K, Purdie C, et al. Invasive breast cancer: relationship between shear-wave elastographic findings and histologic prognostic factors. Radiology. 2012;263:673–7.CrossRef
Metadaten
Titel
Simultaneous comparison between strain and shear wave elastography of breast masses for the differentiation of benign and malignant lesions by qualitative and quantitative assessments
verfasst von
Tomoyuki Fujioka
Mio Mori
Kazunori Kubota
Yuka Kikuchi
Leona Katsuta
Mai Kasahara
Goshi Oda
Toshiyuki Ishiba
Tsuyoshi Nakagawa
Ukihide Tateishi
Publikationsdatum
07.06.2019
Verlag
Springer Japan
Erschienen in
Breast Cancer / Ausgabe 6/2019
Print ISSN: 1340-6868
Elektronische ISSN: 1880-4233
DOI
https://doi.org/10.1007/s12282-019-00985-0

Weitere Artikel der Ausgabe 6/2019

Breast Cancer 6/2019 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.